GB201913338D0 - Treatment of spinal cord injury - Google Patents

Treatment of spinal cord injury

Info

Publication number
GB201913338D0
GB201913338D0 GB201913338A GB201913338A GB201913338D0 GB 201913338 D0 GB201913338 D0 GB 201913338D0 GB 201913338 A GB201913338 A GB 201913338A GB 201913338 A GB201913338 A GB 201913338A GB 201913338 D0 GB201913338 D0 GB 201913338D0
Authority
GB
United Kingdom
Prior art keywords
treatment
spinal cord
cord injury
injury
spinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201913338A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade Nova de Lisboa
Instituto de Medicina Molecular Joao Lobo Antunes
Original Assignee
Universidade Nova de Lisboa
Instituto de Medicina Molecular Joao Lobo Antunes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade Nova de Lisboa, Instituto de Medicina Molecular Joao Lobo Antunes filed Critical Universidade Nova de Lisboa
Priority to GB201913338A priority Critical patent/GB201913338D0/en
Publication of GB201913338D0 publication Critical patent/GB201913338D0/en
Priority to PCT/EP2020/075769 priority patent/WO2021052962A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB201913338A 2019-09-16 2019-09-16 Treatment of spinal cord injury Ceased GB201913338D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201913338A GB201913338D0 (en) 2019-09-16 2019-09-16 Treatment of spinal cord injury
PCT/EP2020/075769 WO2021052962A1 (en) 2019-09-16 2020-09-15 Treatment of spinal cord injury

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201913338A GB201913338D0 (en) 2019-09-16 2019-09-16 Treatment of spinal cord injury

Publications (1)

Publication Number Publication Date
GB201913338D0 true GB201913338D0 (en) 2019-10-30

Family

ID=68315256

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201913338A Ceased GB201913338D0 (en) 2019-09-16 2019-09-16 Treatment of spinal cord injury

Country Status (2)

Country Link
GB (1) GB201913338D0 (en)
WO (1) WO2021052962A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019069070A1 (en) * 2017-10-02 2019-04-11 Eternans Ltd Novel senolytic peptides
WO2020201444A1 (en) * 2019-04-02 2020-10-08 Eternans Ltd Repurposing small molecules for senescence-related diseases and disorders

Also Published As

Publication number Publication date
WO2021052962A1 (en) 2021-03-25

Similar Documents

Publication Publication Date Title
CA186611S (en) Skin treatment device
GB201804514D0 (en) Treatment of pyroptosis
EP3801482A4 (en) Methods for treating spinal cord injury
GB201902419D0 (en) Treatment of kidney injury
EP3840729A4 (en) Treating spinal cord injury (sci) and brain injury using gsx1
GB201804515D0 (en) Treatment of necroptosis
HK1252796A1 (en) Therapeutic agent and/or prophylactic agent for peripheral nerve disorder or spinal injury
EP3750529A4 (en) Composition for prevention and treatment of spinal cord injury
GB2575031B (en) Skin treatment apparatus
GB201805100D0 (en) Treatment of sarcopenic diseases
EP3743085A4 (en) Compositions and methods for treatment of spinal cord injury
GB201913338D0 (en) Treatment of spinal cord injury
GB2598857B (en) Spinal therapy apparatus
IL280638A (en) Fat tissue treatment
IL268111A (en) Methods of treating pain
GB201914516D0 (en) Treatment of eye disease
GB201907305D0 (en) Treatment of conditions
EP3775293C0 (en) Treatment of leather including employing pectin
SG11202011127WA (en) Therapeutic agent for spinal cord injury
CA195803S (en) Skin treatment apparatus
EP3253311A4 (en) Scaffolds for the treatment of spinal cord injuries and diseases
GB201604359D0 (en) Treatment of tissue disorders
IL290983A (en) Methods of treatment
GB201917431D0 (en) Skin treatment apparatus
GB201918853D0 (en) Methods of treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)